• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[骨髓增殖性肿瘤小鼠模型的构建及评估体系]

[Construction of a Mouse Model for Myeloproliferative Neoplasms and an Evaluation System].

作者信息

Wang Shu-Jin, Yu Xiang-Ru, Zhang Qi-Gang, Li Yan-Jie, Fu Chun-Ling, Xu Kai-Lin

机构信息

Blood Diseases Institute, Xuzhou Medical University; Jiangsu Key Laboratory of Bone Marrow Stem Cells;Xuzhou 221000, Jiangsu Province, China.

Blood Diseases Institute, Xuzhou Medical University; Jiangsu Key Laboratory of Bone Marrow Stem Cells; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221000, Jiangsu Province, China.E-mail:

出版信息

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Aug;31(4):1113-1118. doi: 10.19746/j.cnki.issn.1009-2137.2023.04.028.

DOI:10.19746/j.cnki.issn.1009-2137.2023.04.028
PMID:37551485
Abstract

OBJECTIVE

To construct a myeloproliferative neoplasms (MPN) transplanted mouse model with or gene mutation, and establish a systematic evaluation system to verify the success of model construction.

METHODS

The bone marrow c-kit cells of the mice were obtained by the following steps: The mice were killed by cervical dislocation, the femur, tibia and ilium were separated, and the bone marrow cells were collected. The c-kit cells were sorted after incubation with CD117 magnetic beads. The method of constructing mouse primary mutant cells is as follows: A gene mutation vector with a GFP tag was constructed by the retroviral system, and the retroviral vector was packaged into the Platinum-E cells to obtain the virus supernatant, and then used it to infect the c-kit cells of mice. The MPN mouse model was constructed as follows: the mouse primary c-kit cells containing the mutant genes were collected after infection, and then transplanted them via the tail vein into the female recipient mice of the same species which were irradiated with a lethal dose of gamma rays (8.0 Gy). The MPN mouse model was evaluated as follows: After transplantation, the peripheral blood of the mice was regularly collected from the tail vein to perform the complete blood count test, and the size of spleen and the degree of bone marrow fibrosis were estimated.

RESULTS

The mouse c-kit cells with the mutant genes were successfully obtained from the bone marrow. MPN mouse model was successfully constructed: The peripheral blood cells of the MPN-transplanted mice carried exogenous implanted GFP-positive cells, and the white blood cells (WBC), platelet (PLT) and hematocrit (HCT) were all increased; the body weight loss, and the water and food intake were reduced in the transplanted mice; further pathological analysis showed that the transplanted mice displayed splenomegaly and bone marrow fibrosis. These results suggested that the MPN mouse model was successfully constructed. According to the common and different characteristics of the three MPN mouse model, a preliminary evaluation system for judging the success of MPN mouse model construction was summarized, which mainly included the following indicators, for example, the proportion of GFP-positive cells in the peripheral blood of mice; WBC, PLT and HCT; the degree of spleen enlargement and the bone marrow fibrosis.

CONCLUSION

The MPN mouse model with or gene mutation is successfully established by retroviral system, which can provide an important experimental animal model for the research of MPN pathogenesis and drug-targeted therapy.

摘要

目的

构建携带 或 基因突变的骨髓增殖性肿瘤(MPN)移植小鼠模型,并建立系统的评估体系以验证模型构建是否成功。

方法

通过以下步骤获取小鼠骨髓c-kit细胞:颈椎脱臼处死小鼠,分离股骨、胫骨和髂骨,收集骨髓细胞。用CD117磁珠孵育后分选c-kit细胞。构建小鼠原代突变细胞的方法如下:利用逆转录病毒系统构建带有绿色荧光蛋白(GFP)标签的基因突变载体,将逆转录病毒载体包装到Platinum-E细胞中获得病毒上清液,然后用其感染小鼠的c-kit细胞。构建MPN小鼠模型的方法如下:感染后收集含有突变基因的小鼠原代c-kit细胞,然后通过尾静脉将其移植到经致死剂量γ射线(8.0 Gy)照射的同品系雌性受体小鼠体内。对MPN小鼠模型进行如下评估:移植后,定期从小鼠尾静脉采集外周血进行全血细胞计数检测,并评估脾脏大小和骨髓纤维化程度。

结果

成功从骨髓中获得携带突变基因的小鼠c-kit细胞。成功构建了MPN小鼠模型:MPN移植小鼠的外周血细胞携带外源植入的GFP阳性细胞,白细胞(WBC)、血小板(PLT)和血细胞比容(HCT)均升高;移植小鼠体重减轻,水和食物摄入量减少;进一步的病理分析表明,移植小鼠出现脾肿大和骨髓纤维化。这些结果表明成功构建了MPN小鼠模型。根据三种MPN小鼠模型的共同和不同特征,总结了判断MPN小鼠模型构建成功的初步评估体系,主要包括以下指标,例如,小鼠外周血中GFP阳性细胞的比例;WBC、PLT和HCT;脾脏肿大程度和骨髓纤维化程度。

结论

利用逆转录病毒系统成功建立了携带 或 基因突变的MPN小鼠模型,可为MPN发病机制及药物靶向治疗的研究提供重要的实验动物模型。

相似文献

1
[Construction of a Mouse Model for Myeloproliferative Neoplasms and an Evaluation System].[骨髓增殖性肿瘤小鼠模型的构建及评估体系]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Aug;31(4):1113-1118. doi: 10.19746/j.cnki.issn.1009-2137.2023.04.028.
2
Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: from Dameshek 1950 to Vainchenker 2005 and beyond.骨髓增殖性疾病诊断标准的概念变迁以及骨髓增殖性肿瘤的分子病因学与分类:从1950年的达梅谢克到2005年的万琴克尔及以后
Acta Haematol. 2015;133(1):36-51. doi: 10.1159/000358580. Epub 2014 Aug 7.
3
Study of CALR, MPL, and c-kit Gene Mutations in Thai Patients with JAK2 V617F Negative Myeloproliferative Neoplasms.CALR、MPL 和 c-kit 基因突变在 JAK2 V617F 阴性骨髓增殖性肿瘤泰国患者中的研究。
Asian Pac J Cancer Prev. 2022 May 1;23(5):1671-1678. doi: 10.31557/APJCP.2022.23.5.1671.
4
Limited efficacy of BMS-911543 in a murine model of Janus kinase 2 V617F myeloproliferative neoplasm.BMS-911543在JAK2 V617F骨髓增殖性肿瘤小鼠模型中的疗效有限。
Exp Hematol. 2015 Jul;43(7):537-45.e1-11. doi: 10.1016/j.exphem.2015.03.006. Epub 2015 Apr 24.
5
Neutrophil-specific expression of JAK2-V617F or CALRmut induces distinct inflammatory profiles in myeloproliferative neoplasia.中性粒细胞特异性表达 JAK2-V617F 或 CALRmut 可导致骨髓增殖性肿瘤中不同的炎症特征。
J Hematol Oncol. 2024 Jun 9;17(1):43. doi: 10.1186/s13045-024-01562-5.
6
Contributions of bone marrow monocytes/macrophages in myeloproliferative neoplasms with JAK2 mutation.骨髓单核细胞/巨噬细胞在 JAK2 突变的骨髓增殖性肿瘤中的作用。
Ann Hematol. 2023 Jul;102(7):1745-1759. doi: 10.1007/s00277-023-05284-5. Epub 2023 May 26.
7
Deletion of Stat3 in hematopoietic cells enhances thrombocytosis and shortens survival in a JAK2-V617F mouse model of MPN.造血细胞中 Stat3 的缺失可增强 JAK2-V617F 小鼠模型中骨髓增殖性肿瘤的血小板增多症并缩短其生存期。
Blood. 2015 Mar 26;125(13):2131-40. doi: 10.1182/blood-2014-08-594572. Epub 2015 Jan 16.
8
TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms - a multicentric study on 529 patients.TERT rs2736100 A>C SNP 和 JAK2 46/1 单倍型显著导致 JAK2 V617F 和 CALR 突变的骨髓增殖性肿瘤的发生——一项对 529 例患者的多中心研究。
Br J Haematol. 2016 Jul;174(2):218-26. doi: 10.1111/bjh.14041. Epub 2016 Apr 7.
9
SRSF2 mutation reduces polycythemia and impairs hematopoietic progenitor functions in JAK2V617F-driven myeloproliferative neoplasm.SRSF2 突变可减少红细胞增多症,并损害 JAK2V617F 驱动的骨髓增殖性肿瘤中的造血祖细胞功能。
Blood Cancer J. 2023 Nov 27;13(1):171. doi: 10.1038/s41408-023-00947-y.
10
[Analysis of CALR, JAK2 and MPL gene mutations in BCR-ABL negative myeloproliferative neoplasms].[BCR-ABL阴性骨髓增殖性肿瘤中CALR、JAK2和MPL基因突变分析]
Zhonghua Yi Xue Za Zhi. 2015 May 12;95(18):1369-73.